Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia Journal Article


Authors: Oshima, K.; Zhao, J.; Pérez-Durán, P.; Brown, J. A.; Patiño-Galindo, J. A.; Chu, T.; Quinn, A.; Gunning, T.; Belver, L.; Ambesi-Impiombato, A.; Tosello, V.; Wang, Z.; Sulis, M. L.; Kato, M.; Koh, K.; Paganin, M.; Basso, G.; Balbin, M.; Nicolas, C.; Gastier-Foster, J. M.; Devidas, M.; Loh, M. L.; Paietta, E.; Tallman, M. S.; Rowe, J. M.; Litzow, M.; Minden, M. D.; Meijerink, J.; Rabadan, R.; Ferrando, A.
Article Title: Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia
Abstract: Multiagent combination chemotherapy can be curative in acute lymphoblastic leukemia (ALL). Still, patients with primary refractory disease or with relapsed leukemia have a very poor prognosis. Here we integrate an in-depth dissection of the mutational landscape across diagnostic and relapsed pediatric and adult ALL samples with genome-wide CRISPR screen analysis of gene–drug interactions across seven ALL chemotherapy drugs. By combining these analyses, we uncover diagnostic and relapse-specific mutational mechanisms as well as genetic drivers of chemoresistance. Functionally, our data identify common and drug-specific pathways modulating chemotherapy response and underscore the effect of drug combinations in restricting the selection of resistance-driving genetic lesions. In addition, by identifying actionable targets for the reversal of chemotherapy resistance, these analyses open therapeutic opportunities for the treatment of relapse and refractory disease. © 2020, The Author(s), under exclusive licence to Springer Nature America, Inc.
Journal Title: Nature Cancer
Volume: 1
Issue: 11
ISSN: 2662-1347
Publisher: Nature Research  
Date Published: 2020-11-01
Start Page: 1113
End Page: 1127
Language: English
DOI: 10.1038/s43018-020-00124-1
PROVIDER: scopus
PMCID: PMC8011577
PUBMED: 33796864
DOI/URL:
Notes: Article -- Export Date: 1 December 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Martin Stuart Tallman
    649 Tallman
  2. Maria Luisa Sulis
    42 Sulis